In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

Scientists have developed a new molecule that breaks down beta-amyloid plaques by binding to excess copper in the brain. The treatment restored memory and reduced inflammation in rats, while also ...

Turning its focus to neurology and following a successful acquisition of Life Molecular Imaging, Lantheus is on the path to revolutionize Alzheimer’s disease diagnosis by advancing its two late-stage ...